Metabolic syndrome and cognitive decline

Current Alzheimer Research

Volumn 4, Issue 2, 2007, Pages 123-126

  Yaffe, Kristine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognition; Dementia; Insulin resistance; Metabolic syndrome

Indexed keywords

ABDOMINAL OBESITY; AGING; CARDIOVASCULAR RISK; COGNITION; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; MEDICAL RESEARCH; METABOLIC SYNDROME X; OBESITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VASCULAR DISEASE;

ADIPOSITY; COGNITION DISORDERS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC DISEASES; VASCULAR DISEASES;

EID: 34147119059     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720507780362191     Document Type: Review

References (39)

1. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147(6): 574-80 (1998).
2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88(9): 1337-42 (1998).
3. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19): 2486-97 (2001).
4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3): 356-9 (2002).
5. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 274(23): 1846-51 (1995).
6. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4(8): 487-99 (2005).
7. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164(12): 1327-33 (2004).
8. Grodstein F, Chen J, Wilson RS, Manson JE. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24(6): 1060-5 (2001).
9. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160(2): 174-80 (2000).
10. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63(4): 658-63 (2004).
11. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 59(3): 378-84 (2002).
12. Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K, et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 282(3): 254-60 (1999).
13. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163(13): 1524-8 (2003).
14. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr., Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005.
15. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 20(10): 2255-60 (2000).
16. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56(1): 42-8 (2001).
17. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64(2): 277-81 (2005).
18. McGeer EG, McGeer PL. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des 5(10): 821-36 (1999).
19. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292(18): 2237-42 (2004).
20. Census US. National Population Projections. Washington, DC: U.S. Government Printing Office, 2000.
21. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 51(2): 169-77 (2003).
22. Yaffe K, Haan MN, Blackwell T, Whitmer RA, West N. Metabolic Syndrome and Cognitive Decline in Elderly Latinos: Findings from the SALSA Study. American Academy of Neurology 2006, San Diego, CA.
23. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 1(1): 61-77(2002).
24. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154(7): 635-41 (2001).
25. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama 286(3): 327-34 (2001).
26. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50(10): 2384-9 (2001).
27. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in wellfunctioning African-American and white elders. Neurology 61(1): 76-80 (2003).
28. Grundy SM. Inflammation, hypertension, and the metabolic syndrome. Jama 290(22): 3000-2 (2003).
29. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107(3): 391-7 (2003).
30. Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin as adiposity signals. Recent Prog Horm Res 59: 267-85 (2004).
31. Harvey J. Leptin: a multifaceted hormone in the central nervous system. Mol Neurobiol 28(3): 245-58 (2003).
32. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N. Obesity-related leptin regulates Alzheimer's Abeta. Faseb J 18(15): 1870-8 (2004).
33. Zamboni M, Zoico E, Fantin F, Panourgia MP, Di Francesco V, Tosoni P, et al. Relation between leptin and the metabolic syndrome in elderly women. J Gerontol A Biol Sci Med Sci 59(4): 396-400 (2004).
34. Holden KF, Lindquist K, Rosano C, Tylavsky FA, Harris T, Yaffe K. Low serum leptin is associated with poor cognitive performance in the elderly. American Academy of Neurology San Diego, CA (2006).
35. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol 62(10): 1545-8 (2005).
36. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 63(7): 1187-92 (2004).
37. Yaffe K, Blackwell T, Whitmer RA, Krueger K, Barrett Connor E. Glycosylated Hemoglobin Level and Development of Mild Cognitive Impairment or Dementia in OlderWomen. J Nutr Health Aging 10(4): 293-5 (2006).
38. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100(7): 4162-7 (2003).
39. Kulstad JJ, Green PS, Cook DG, Watson GS, Reger MA, Baker LD, et al. Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease. Neurology 66(10): 1506-10 (2006).